Enforcement Report - Week of April 5, 2017
Mylan Institutional's Generic Bivalirudin Receives Tentative Approval In US
Mylan Institutional, Inc. recalls Clonazepam Tablets, USP, 0.5 mg due to failed Impurities Specifications
Mylan (MYL) CEO Says Pfizer (PFE) Should Come Calling, As Next Big Deal Speculation Swirls
Teva Sends Letter to Mylan Board.